Market Cap 68.99M
Revenue (ttm) 0.00
Net Income (ttm) 4.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 562,200
Avg Vol 3,535,562
Day's Range N/A - N/A
Shares Out 106.46M
Stochastic %K 19%
Beta 0.09
Analysts Strong Sell
Price Target $0.90

Company Profile

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has co...

Industry: Asset Management
Sector: Financial Services
Phone: 617 714 0360
Address:
47 Thorndike Street, Suite B1-1, Cambridge, United States
StockDreamin
StockDreamin Aug. 14 at 4:14 PM
0 · Reply
StockDreamin
StockDreamin Aug. 13 at 4:35 PM
$CYPH decent earnings, promising future of drug phase 3....then it shits the bed!
0 · Reply
Slambucket
Slambucket Aug. 13 at 4:19 PM
$CYPH - What’s this talk about a spinoff of the biotech assets?
2 · Reply
StockDreamin
StockDreamin Aug. 13 at 3:31 PM
$CYPH We got hoodWinkled!
0 · Reply
StockDreamin
StockDreamin Aug. 13 at 3:33 AM
$CYPH that whole security scam with $ZEC.X is what killed the momentum...perfectly coordinated scam...and now .63 is the new .73
0 · Reply
RushingPatience
RushingPatience Aug. 13 at 1:38 AM
$CYPH I feel the Leap asset is way more valuable than ZEC. still in for this reason.
0 · Reply
StockDreamin
StockDreamin Aug. 12 at 6:47 PM
$CYPH $ZEC.X goes up, this goes down! Fun!
1 · Reply
FreeWill1959
FreeWill1959 Aug. 12 at 11:48 AM
$CYPH "We are conducting a strategic process to determine the best path to advance sirexatamab, whether as an independently financed spin-out company or with a partner who shares our commitment to cancer patients." We are sitting on a "Pot of Gold" IMHO, GLTA longs.
0 · Reply
Hammerhead1
Hammerhead1 Aug. 12 at 11:41 AM
$CYPH $CYPH looking increasingly interesting. ZEC treasury value is strong, and Leap is also showing real progress with positive Phase 2 data and a clearer Phase 3 path. More than just a Zcash proxy now. 🚀
0 · Reply
bionicman1969
bionicman1969 Aug. 12 at 11:21 AM
$CYPH no need to own this stock just buy $ZEC.X then sell $ZEC.X too based on new tech making zero knowledge outdated and inefficient
0 · Reply
Latest News on CYPH
Cypherpunk Technologies Earnings release: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 2 days ago

Cypherpunk Technologies Earnings release: Q2 2026


Cypherpunk Technologies Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 2 days ago

Cypherpunk Technologies Quarterly report: Q2 2026


Cypherpunk Technologies Transcript: AGM 2026

Jun 18, 2026, 11:00 AM EDT - 2 months ago

Cypherpunk Technologies Transcript: AGM 2026


Cypherpunk Technologies Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cypherpunk Technologies Quarterly report: Q1 2026


Cypherpunk Technologies Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cypherpunk Technologies Earnings release: Q1 2026


Cypherpunk Technologies Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Cypherpunk Technologies Proxy statement: Proxy filing


Cypherpunk Technologies Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Cypherpunk Technologies Proxy statement: Proxy filing


Cypherpunk Technologies increases Zcash stake for $2.15M

2026-04-15T16:25:49.000Z - 4 months ago

Cypherpunk Technologies increases Zcash stake for $2.15M


Cypherpunk Reports Full Year 2025 Financial Results

Mar 16, 2026, 4:50 PM EDT - 5 months ago

Cypherpunk Reports Full Year 2025 Financial Results


Cypherpunk Technologies Annual report: Q4 2025

Mar 16, 2026, 4:00 PM EDT - 5 months ago

Cypherpunk Technologies Annual report: Q4 2025


Cypherpunk Technologies Earnings release: Q4 2025

Mar 16, 2026, 4:00 PM EDT - 5 months ago

Cypherpunk Technologies Earnings release: Q4 2025


Cypherpunk Adds Arjun Khemani as Strategic Advisor

Jan 22, 2026, 7:00 AM EST - 7 months ago

Cypherpunk Adds Arjun Khemani as Strategic Advisor


Cypherpunk Technologies purchases additional $29M of ZEC

2025-12-30T12:10:18.000Z - 8 months ago

Cypherpunk Technologies purchases additional $29M of ZEC


Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor

Dec 19, 2025, 7:00 AM EST - 8 months ago

Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor


Cypherpunk Technologies Transcript: AGM 2025

Dec 15, 2025, 11:00 AM EST - 8 months ago

Cypherpunk Technologies Transcript: AGM 2025


Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor

Dec 9, 2025, 7:00 AM EST - 8 months ago

Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor


Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 19, 2025, 7:00 AM EST - 9 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies purchases additional $18M of ZEC

2025-11-18T12:21:34.000Z - 9 months ago

Cypherpunk Technologies purchases additional $18M of ZEC


Cypherpunk Technologies Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Cypherpunk Technologies Earnings release: Q3 2025


Cypherpunk Technologies Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Cypherpunk Technologies Quarterly report: Q3 2025


Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 9 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 10 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Nov 3, 2025, 7:00 AM EST - 10 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 10 months ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Earnings release: Q2 2025


Cypherpunk Technologies Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Quarterly report: Q2 2025


Cypherpunk Technologies Earnings release: Q1 2025

May 13, 2025, 9:30 AM EDT - 1 year ago

Cypherpunk Technologies Earnings release: Q1 2025


Cypherpunk Technologies Quarterly report: Q1 2025

May 13, 2025, 9:30 AM EDT - 1 year ago

Cypherpunk Technologies Quarterly report: Q1 2025


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Transcript: Status Update

Apr 23, 2025, 2:30 PM EDT - 1 year ago

Cypherpunk Technologies Transcript: Status Update


Cypherpunk Technologies Annual report: Q4 2024

Mar 26, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Annual report: Q4 2024


Cypherpunk Technologies Earnings release: Q4 2024

Mar 26, 2025, 7:00 AM EDT - 1 year ago

Cypherpunk Technologies Earnings release: Q4 2024


Cypherpunk Technologies Transcript: Study Result

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Transcript: Study Result


Cypherpunk Technologies Press release: Study Result

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Press release: Study Result


Cypherpunk Technologies Slides: Study Result

Jan 28, 2025, 8:00 AM EST - 1 year ago

Cypherpunk Technologies Slides: Study Result


Cypherpunk Technologies Slides: FY 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

Cypherpunk Technologies Slides: FY 2025


Cypherpunk Technologies Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Cypherpunk Technologies Earnings release: Q3 2024


Cypherpunk Technologies Quarterly report: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Cypherpunk Technologies Quarterly report: Q3 2024


Leap Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports Second Quarter 2024 Financial Results


Cypherpunk Technologies Quarterly report: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Quarterly report: Q2 2024


Cypherpunk Technologies Earnings release: Q2 2024

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q2 2024


Cypherpunk Technologies Proxy statement: Proxy Filing

May 16, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Leap Therapeutics Reports First Quarter 2024 Financial Results

May 13, 2024, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports First Quarter 2024 Financial Results


Cypherpunk Technologies Quarterly report: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Quarterly report: Q1 2024


Cypherpunk Technologies Earnings release: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q1 2024


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Leap Therapeutics Announces $40 Million Private Placement

Apr 11, 2024, 8:30 AM EDT - 2 years ago

Leap Therapeutics Announces $40 Million Private Placement


Cypherpunk Technologies Annual report: Q4 2023

Mar 18, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Annual report: Q4 2023


Cypherpunk Technologies Earnings release: Q4 2023

Mar 18, 2024, 8:00 AM EDT - 2 years ago

Cypherpunk Technologies Earnings release: Q4 2023


Cypherpunk Technologies Transcript: Study Update

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Transcript: Study Update


Cypherpunk Technologies Press release: Study Update

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Press release: Study Update


Cypherpunk Technologies Slides: Study Update

Jan 23, 2024, 8:30 AM EST - 2 years ago

Cypherpunk Technologies Slides: Study Update


Cypherpunk Technologies Slides: FY 2024

Jan 10, 2024, 4:30 PM EST - 2 years ago

Cypherpunk Technologies Slides: FY 2024


Leap Therapeutics Reports Third Quarter 2023 Financial Results

Nov 13, 2023, 7:00 AM EST - 2 years ago

Leap Therapeutics Reports Third Quarter 2023 Financial Results


Cypherpunk Technologies Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Cypherpunk Technologies Quarterly report: Q3 2023


Leap Therapeutics Reports Second Quarter 2023 Financial Results

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports Second Quarter 2023 Financial Results


Cypherpunk Technologies Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Quarterly report: Q2 2023


Cypherpunk Technologies Earnings release: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q2 2023


Leap Therapeutics Announces Reverse Stock Split

Jun 20, 2023, 12:30 PM EDT - 3 years ago

Leap Therapeutics Announces Reverse Stock Split


Leap Therapeutics Reports First Quarter 2023 Financial Results

May 15, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports First Quarter 2023 Financial Results


Cypherpunk Technologies Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Quarterly report: Q1 2023


Cypherpunk Technologies Earnings release: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q1 2023


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Proxy statement: Proxy Filing

Apr 14, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


Cypherpunk Technologies Annual report: Q4 2022

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Annual report: Q4 2022


Cypherpunk Technologies Earnings release: Q4 2022

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Earnings release: Q4 2022


Cypherpunk Technologies Proxy statement: Proxy Filing

Mar 24, 2023, 8:00 AM EDT - 3 years ago

Cypherpunk Technologies Proxy statement: Proxy Filing


StockDreamin
StockDreamin Aug. 14 at 4:14 PM
0 · Reply
StockDreamin
StockDreamin Aug. 13 at 4:35 PM
$CYPH decent earnings, promising future of drug phase 3....then it shits the bed!
0 · Reply
Slambucket
Slambucket Aug. 13 at 4:19 PM
$CYPH - What’s this talk about a spinoff of the biotech assets?
2 · Reply
StockDreamin
StockDreamin Aug. 13 at 3:31 PM
$CYPH We got hoodWinkled!
0 · Reply
StockDreamin
StockDreamin Aug. 13 at 3:33 AM
$CYPH that whole security scam with $ZEC.X is what killed the momentum...perfectly coordinated scam...and now .63 is the new .73
0 · Reply
RushingPatience
RushingPatience Aug. 13 at 1:38 AM
$CYPH I feel the Leap asset is way more valuable than ZEC. still in for this reason.
0 · Reply
StockDreamin
StockDreamin Aug. 12 at 6:47 PM
$CYPH $ZEC.X goes up, this goes down! Fun!
1 · Reply
FreeWill1959
FreeWill1959 Aug. 12 at 11:48 AM
$CYPH "We are conducting a strategic process to determine the best path to advance sirexatamab, whether as an independently financed spin-out company or with a partner who shares our commitment to cancer patients." We are sitting on a "Pot of Gold" IMHO, GLTA longs.
0 · Reply
Hammerhead1
Hammerhead1 Aug. 12 at 11:41 AM
$CYPH $CYPH looking increasingly interesting. ZEC treasury value is strong, and Leap is also showing real progress with positive Phase 2 data and a clearer Phase 3 path. More than just a Zcash proxy now. 🚀
0 · Reply
bionicman1969
bionicman1969 Aug. 12 at 11:21 AM
$CYPH no need to own this stock just buy $ZEC.X then sell $ZEC.X too based on new tech making zero knowledge outdated and inefficient
0 · Reply
focafoca99
focafoca99 Aug. 12 at 11:21 AM
$CYPH states its Q2 2026 results and a Phase 2 study release from Leap Therapeutics.
1 · Reply
YoloAlfred
YoloAlfred Aug. 12 at 11:08 AM
$CYPH thank you.....
0 · Reply
FamilyTime444
FamilyTime444 Aug. 5 at 10:48 PM
$SOUN entering energy in automotive already and healthcare $CYPH $BAC $UBER
0 · Reply
Kobe2324
Kobe2324 Aug. 5 at 12:20 PM
$CYPH if you want to lose money buy this stock. Awful place
0 · Reply
Hegotgame88
Hegotgame88 Aug. 4 at 6:08 PM
0 · Reply
bionicman1969
bionicman1969 Aug. 3 at 4:10 AM
$CYPH this can be a zero bid situation if ZAMA protocol makes $ZEC.X obsolete. Downgrading to SELL.
0 · Reply
atechniqueisause
atechniqueisause Aug. 3 at 12:33 AM
$CYPH Twinkle toes twinks. Horrible.
0 · Reply
LongHaulHenry
LongHaulHenry Jul. 30 at 1:57 PM
$CYPH wtf even is this anymore. Who's been here since the biotech days?
1 · Reply
Lundo
Lundo Jul. 29 at 11:08 PM
$CYPH privacy
0 · Reply
DATCAP
DATCAP Jul. 23 at 6:43 PM
$CYPH $CYPH holds 321,032 ZEC with no debt or preferred stock, yet trades around 0.77x NAV. A rerating becomes more plausible if ZEC strengthens and CYPH avoids issuing common below NAV. With a clean capital stack, there is little else obscuring the thesis. Closing the discount to 1.0x would add roughly 31% before any ZEC move.
0 · Reply
PtonProphet
PtonProphet Jul. 22 at 8:43 PM
$CYPH we complied last time let’s do it again (chart looks absolutely miserable rn
0 · Reply
DATCAP
DATCAP Jul. 20 at 6:41 PM
$CYPH’s goal of owning 5% of the ZEC network has become a capital-structure problem. Its 321,032 ZEC represent 1.91% of supply, leaving roughly 519,000 ZEC to reach the target at today’s network size. The 75.99M warrants struck at $0.5335 could provide about $40.5M. Even if every dollar bought ZEC near today’s $551 price, that adds only about 73,500 ZEC, or 14% of the remaining gap. Meanwhile, the economic share count rises from 187.23M to 263.22M, reducing ZEC per share by roughly 12.6%, before counting the 16.68M RSUs. The 5% target may be achievable in absolute coins. Reaching it while preserving holdings per share (HPS) is the harder problem.
1 · Reply